Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study.

Mease, Philip; Elaine Husni, M; Chakravarty, Soumya D; Kafka, Shelly; Parenti, Dennis; Kim, Lilianne; Hung Lo, Kim; Hsia, Elizabeth C; Kavanaugh, Arthur

Mease, Philip; Elaine Husni, M; Chakravarty, Soumya D; Kafka, Shelly; Parenti, Dennis; Kim, Lilianne; Hung Lo, Kim; Hsia, Elizabeth C; Kavanaugh, Arthur.

Afiliación

Mease P; Swedish Medical Center, Seattle, Washington and University of Washington School of Medicine, Seattle.
Elaine Husni M; Cleveland Clinic, Cleveland, Ohio.
Chakravarty SD; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, and, Drexel University College of Medicine, Philadelphia, PA.
Kafka S; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania.
Parenti D; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania.
Kim L; Janssen Research & Development, LLC, Spring House, Pennsylvania.
Hung Lo K; Janssen Research & Development, LLC, Spring House, Pennsylvania.
Hsia EC; Janssen Research & Development, LLC, Spring House, Pennsylvania, and University of Pennsylvania, Philadelphia.
Kavanaugh A; University of California, San Diego.

ACR Open Rheumatol ; 2(11): 640-647, 2020 Nov.

Article en En | MEDLINE | ID: mdl-33073933

Palabras clave

DLQI; intravenous golimumab; mNAPSI; psoriasis; psoriatic arthritis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: ACR Open Rheumatol Año: 2020 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google